Iovance Biotherapeutics, Inc. (IOVA) vs Viking Therapeutics, Inc. (VKTX)
Iovance Biotherapeutics, Inc. and Viking Therapeutics, Inc. are both Biotechnology companies. Iovance Biotherapeutics, Inc. is the larger, with a market value of $4.9B against $4.3B — 1.1× the size. Viking Therapeutics, Inc. has the higher net margin (0.00% vs −89.1%) and the higher return on invested capital (0.00% vs −43.0%). Across the 13 metrics below, Iovance Biotherapeutics, Inc. leads on 8 and Viking Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | IOVA | VKTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 48.40% | 0.00% | 65.16% |
| Operating margin | (92.72%) | 0.00% | 0.00% |
| Net margin | (89.09%) | 0.00% | 0.00% |
| Free cash flow margin | (91.21%) | 0.00% | 0.00% |
| Return on equity | (40.36%) | (88.85%) | (57.72%) |
| Return on assets | (31.76%) | (79.24%) | (49.22%) |
| Return on invested capital | (42.96%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack